This review of significant changes, additions, and removals to the Bullseye Chart is exclusively for Pα+ subscribers. If you’re not yet a subscriber, you can still view the Bullseye Chart and our Psychedelic Drug Development Tracker. To continue reading, please log in or join Pα+… Independent data-driven reporting, analysis and commentary on the psychedelics space…

Source

Previous articleQ1’25 Psychedelic Drug Development Pipeline: Bullseye Chart
Next articleThe Psychedelic News Feed: September 2, 2024 – December 29, 2024